ClinConnect ClinConnect Logo
Search / Trial NCT07109141

Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland

Launched by WROCLAW MEDICAL UNIVERSITY · Jul 31, 2025

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on gathering information about a newer treatment called Pulsed Field Ablation (PFA) used to treat irregular heart rhythms, such as atrial fibrillation, atrial flutter, and atrial tachycardia. These conditions affect the heart’s rhythm and can cause symptoms like palpitations or fatigue. The trial is creating a national database in Poland to collect details about how well PFA works and how safe it is when used in different hospitals.

People who are 65 years or older and are having a PFA procedure to treat their irregular heart rhythm may be eligible to join, as long as they agree to participate. If you take part, your doctors will collect information about your treatment and recovery to help improve understanding of this procedure for future patients. This study is currently open and recruiting participants, and it offers a chance to contribute to research on a promising heart treatment.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Informed consent obtained from the participant
  • Subject is undergoing ablation of an atrial arrhythmia using the PFA
  • Exclusion Criteria:
  • -

About Wroclaw Medical University

Wrocław Medical University is a prestigious academic institution located in Wrocław, Poland, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in healthcare and biomedical sciences to facilitate innovative research initiatives aimed at improving patient outcomes. With a strong emphasis on ethical practices and regulatory compliance, Wrocław Medical University collaborates with a diverse network of healthcare professionals and researchers to conduct rigorous clinical trials that contribute to the development of new therapies and enhance the understanding of various medical conditions. Its dedication to scientific excellence and patient safety positions the university as a key player in the global clinical research landscape.

Locations

Wroclaw, Dolnoslaskie, Poland

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported